---
title: 'Employing Hexahydroquinolines as <em>Pf</em>CDPK4 Inhibitors to Combat Malaria
  Transmission: An Advanced Computational Approach'
date: '2024-09-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39345873/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240930184655&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Comparative analysis of this compound with BKI-1294 using
  advanced computational approaches demonstrated competitive potential. These findings
  suggest the potential of 4-[4-(Furan-2-carbonyl)piperazin-1-yl]-1-(naphthalen-2-ylmethyl)-2-oxo-4a,5,6,7,8,8a-hexahydroquinoline-3-carbonitrile
  as a promising PfCDPK4 inhibitor for disrupting malaria transmission. However, further
  experimental studies are warranted to validate its efficacy and safety ...'
disable_comments: true
---
CONCLUSION: Comparative analysis of this compound with BKI-1294 using advanced computational approaches demonstrated competitive potential. These findings suggest the potential of 4-[4-(Furan-2-carbonyl)piperazin-1-yl]-1-(naphthalen-2-ylmethyl)-2-oxo-4a,5,6,7,8,8a-hexahydroquinoline-3-carbonitrile as a promising PfCDPK4 inhibitor for disrupting malaria transmission. However, further experimental studies are warranted to validate its efficacy and safety ...